Keiji AI LogoKeiji AI

Target & Mechanism Discovery

Discover and validate therapeutic targets faster with AI-driven mechanism analysis and target prioritization.

Molecular Subtype Discovery
Differential Expression Analysis
Pathway Enrichment Analysis
Pathway Visualization
1

Molecular Subtype Discovery

Cluster patients into molecular subtypes using K-means clustering on mRNA expression profiles. Perform survival analysis with Kaplan-Meier curves and log-rank tests to identify prognostically significant subtypes.

Features

Key Capabilities

Multi-omics data integration for target identification

Pathway analysis and mechanism of action modeling

Target druggability assessment and prioritization

Disease-target association mining from literature

Genetic evidence scoring and validation

Competitive target landscape analysis

Typical Users

Discovery ScientistsComputational BiologistsResearch DirectorsTarget Assessment Teams

Ready to Transform Your Workflow?

See how TrialMind can accelerate your clinical trial operations with AI-powered automation.

Trusted Partners

Trusted by Leading Organizations

From top pharma companies to academic medical centers

AbbVie logo
Regeneron logo
Takeda logo
Guardant Health logo
Medidata logo
Beth Israel Deaconess Medical Center logo
AbbVie logo
Regeneron logo
Takeda logo
Guardant Health logo
Medidata logo
Beth Israel Deaconess Medical Center logo